Journal of the American College of Cardiology
AHA/ACCF/ESC Scientific Statement
The Role of Endomyocardial Biopsy in the Management of Cardiovascular DiseaseA Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
Leslie T. Cooper, Kenneth L. Baughman, Arthur M. Feldman, Andrea Frustaci, Mariell Jessup, Uwe Kuhl, Glenn N. Levine, Jagat Narula, Randall C. Starling, Jeffrey Towbin and Renu Virmani
Table 1
Table 1
Risks Associated With Endomyocardial Biopsy in 546 Procedures
| Overall 33 complications (6%) |
| Sheath insertion 15 (2.7%) |
| 12 (2.0%) arterial puncture during local anesthesia |
| 2 (0.4%) vasovagal reaction |
| 1 (0.2%) prolonged venous oozing after sheath removal |
| Biopsy procedure 18 (3.3%) |
| 6 (1.1%) arrhythmia |
| 5 (1.0%) conduction abnormalities |
| 4 (0.7%) possible perforation (pain) |
| 3 (0.5%) definite perforation (pericardial fluid) |
| 2 of 3 patients with definite perforation died |
Data derived from Deckers et al (20).
Advertisement